Tech Company M&A Transactions

MedImmune Acquisition

Headquartered in Gaithersburg, MedImmune was acquired by AstraZeneca. Deal value was $15.6 billion.

Transaction Overview

Company Name
Acquired By
Announced On
4/23/2007
Transaction Type
M&A
Amount
$15,600,000,000
M&A Terms
Under the terms of the agreement, which has unanimous MedImmune Board support, AstraZeneca will acquire all of the fully diluted shares of MedImmune common stock at a price of $58 per share, for a total consideration of approximately $15.6 billion (including approximately $340m net cash).

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Medimmune Way
Gaithersburg, MD 20878
USA
Email Address
Overview
At MedImmune our core therapeutic areas are Oncology; Respiratory, Inflammation & Autoimmune, and Cardiovascular & Metabolic Disease.
Profile
MedImmune LinkedIn Company Profile
Social Media
MedImmune Company Twitter Account
Company News
MedImmune News
Facebook
MedImmune on Facebook
YouTube
MedImmune on YouTube

Management Team

Title
Name
Email & Social
Chief Operating Officer
Matthew Bell
  Matthew Bell LinkedIn Profile  Matthew Bell Twitter Account  Matthew Bell News  Matthew Bell on Facebook
President
Bahija Jallal
  Bahija Jallal LinkedIn Profile  Bahija Jallal Twitter Account  Bahija Jallal News  Bahija Jallal on Facebook
Vice President
Scott Alban
  Scott Alban LinkedIn Profile  Scott Alban Twitter Account  Scott Alban News  Scott Alban on Facebook
Vice President
Badrul Chowdhury
  Badrul Chowdhury LinkedIn Profile  Badrul Chowdhury Twitter Account  Badrul Chowdhury News  Badrul Chowdhury on Facebook
Vice President
Mohammed Dar
  Mohammed Dar LinkedIn Profile  Mohammed Dar Twitter Account  Mohammed Dar News  Mohammed Dar on Facebook
VP - Bus. Development
Gail Folena-Wasserman
  Gail Folena-Wasserman LinkedIn Profile  Gail Folena-Wasserman Twitter Account  Gail Folena-Wasserman News  Gail Folena-Wasserman on Facebook
VP - Finance
James Brady
  James Brady LinkedIn Profile  James Brady Twitter Account  James Brady News  James Brady on Facebook
VP - R & D
Jane Osbourn
  Jane Osbourn LinkedIn Profile  Jane Osbourn Twitter Account  Jane Osbourn News  Jane Osbourn on Facebook
VP - R & D
Cristina Rondinone
  Cristina Rondinone LinkedIn Profile  Cristina Rondinone Twitter Account  Cristina Rondinone News  Cristina Rondinone on Facebook
VP - R & D
Jean-Charles Soria
  Jean-Charles Soria LinkedIn Profile  Jean-Charles Soria Twitter Account  Jean-Charles Soria News  Jean-Charles Soria on Facebook
VP - R & D
JoAnn Suzich
  JoAnn Suzich LinkedIn Profile  JoAnn Suzich Twitter Account  JoAnn Suzich News  JoAnn Suzich on Facebook
VP - Regulatory Affairs
Tracy Rossin
  Tracy Rossin LinkedIn Profile  Tracy Rossin Twitter Account  Tracy Rossin News  Tracy Rossin on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/23/2007: AmberPoint venture capital transaction
Next: 4/23/2007: Acclarent venture capital transaction

 

Share this article

 


About Database of VC Transactions

We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary